Drug Pricing

WASHINGTON, D.C. – Today, Sen. Peter Welch (D-Vt.) hosted a panel discussion with Sen. Amy Klobuchar (D-Minn.), health care experts, and patient advocates, focused on Big Pharma’s use of so-called patent 'thickets' to prevent generic and biosimilar drugs from entering the market, and the harmful…

WASHINGTON, D.C. – Senator Peter Welch (D-Vt.) today celebrated the White House’s announcement that it has sent initial negotiation offers through Medicare for the first 10 prescription drugs, selected last August, that are subject to price negotiation under the Inflation Reduction Act (IRA). Pharmaceutical companies…

WASHINGTON - Senators Peter Welch (D-Vt.) and Amy Klobuchar (D-Minn.) as well as Senators John Hickenlooper (D-Colo.), Elizabeth Warren (D-Mass.), Chris Van Hollen (D-Md.), Richard Blumenthal (D-Conn.), Tammy Baldwin (D-Wis.), Jacky Rosen (D-Nev.), Sherrod Brown (D-Ohio), Dick Durbin (D-Ill.), John Fetterman (D-Pa.), Debbie Stabenow (D-Mich.),…

WASHINGTON, D.C. – This week, Sen. Peter Welch (D-Vt.) took to the Senate floor to call out Big Pharma’s fear-mongering and scare tactics about Congressional Democrats and the White House’s fight to lower prescription drug costs for seniors. The White House recently unveiled the first…

Inflation Reduction Act’s drug price negotiations are a longtime legislative priority of Sen. Welch WASHINGTON, D.C. – Senator Peter Welch (D-Vt.) today joined Families USA and Patients for Affordable Drugs for a virtual press conference celebrating the White House’s recent announcement of the first ten…